Besides this, patients with stable CAD and high OPN levels had a greater risk of adverse cardiovascular events during the mean follow-up period of 2.7 years (HR: 1.88; CI: 1.35–2.62, p < 0.001) [65]. The gene discussed is SPP1; the disease is coronary artery disorder.